| |
| Migraine is the most common form of headache with high prevalence in western countries. About 15-17% of women and 5-7% of men are affected by this disorder. Though migraine may occur in all age groups, it is highly prevalent in the age group of 18-45 years. |
 |
| Migraine attacks are characterized by recurrent headaches, unilateral/bilateral positions, pulsating in nature with moderate to severe intensity causing debility. Therefore, migraine has been ranked 19 among the debility causing diseases by World Health Organization. |
|
| There is no known cause for migraine. Though diverse theories are brought forward time to time by experts yet none of these are able to provide long-term prophylactic treatment. On the contrary, the prolonged use of pain killers further triggers the Medication Overuse Headache (MOH) or other side-effects. In the above background, the ongoing results obtained from the multiple Ayurvedic clinics at Bangalore, Mysore, Tumkur, Bellary, Shimoga and Hubli (Karnataka), Aurangabad (Maharashtra), Warangal and Hyderabad (Andhra Pradesh), and previous results of the first prospective study at Chandigarh conclusively prove that Ayurvedictherapy (AYT)* is efficacious as or even better than anti migraine medication available today. See second annual report- figure 1 |
| |
|
| The results of such observations have been presented in poster forms at 16th International Symposium on Migraine, London September 2006 - figure 2 and 13th Congress on Headache, Stockholm, Sweden, June/july 2007 - figure 3 The Subsequent poster abstracts got |
| |
|
|
| published in Cephalalgia, number 26, volume 11, 1367 and Cephalagia, 2007, 27, 745 respectively. The said journals published by International Headache Society.The results of the ongoing study, reveals that the migraineurs who completed 120 days AYT with good compliance of lifestyle and diet have no signs and symptoms of migraine and are leading a normal life. It will be worthwhile to note that none of the ingredient of AYT has analgesic or sedative effect.AYT is well tolerated and did not cause any noticeable side effect among treated patients. |
|
| Safety Studies: AYT Migraine have been studied for acute and subacute toxicological in rat and mice. The studies reveal that AYT is absolute safe at the given doses and duration. Long term safety studies are in progress. The data is available on file and will be send for publication in near future. |
|
| Reproducibility of AYT: The products are manufactured by BBS Pvt Ltd. at Dehradun, India. by developing standard quality assurance. AYT is manufactured under Ayurvedic manufacturing Lincenced granted by department of AYUSH, federal government of Uttarakhand, India |
|
x
|
|
PPT on evidently effective
Indegenous treatment for
migraine. |
|
| • |
|
 |
|
|
| |
|
|
| |
*The stated efficacy for migraine is to be validated by combining traditional knowledge with technology. Ipca TR invites prospective researcher/s and instituition for collabration. |
|
|
|
| |
| AYT for migraine is available to the patients in India. For further details contact us. |
| |
|
|
